These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
720 related articles for article (PubMed ID: 21478152)
1. Resistin promotes cardiac hypertrophy via the AMP-activated protein kinase/mammalian target of rapamycin (AMPK/mTOR) and c-Jun N-terminal kinase/insulin receptor substrate 1 (JNK/IRS1) pathways. Kang S; Chemaly ER; Hajjar RJ; Lebeche D J Biol Chem; 2011 May; 286(21):18465-73. PubMed ID: 21478152 [TBL] [Abstract][Full Text] [Related]
2. Evodiamine inhibits insulin-stimulated mTOR-S6K activation and IRS1 serine phosphorylation in adipocytes and improves glucose tolerance in obese/diabetic mice. Wang T; Kusudo T; Takeuchi T; Yamashita Y; Kontani Y; Okamatsu Y; Saito M; Mori N; Yamashita H PLoS One; 2013; 8(12):e83264. PubMed ID: 24391749 [TBL] [Abstract][Full Text] [Related]
3. Inhibition of the mTOR/p70S6K pathway is not involved in the insulin-sensitizing effect of AMPK on cardiac glucose uptake. Ginion A; Auquier J; Benton CR; Mouton C; Vanoverschelde JL; Hue L; Horman S; Beauloye C; Bertrand L Am J Physiol Heart Circ Physiol; 2011 Aug; 301(2):H469-77. PubMed ID: 21602475 [TBL] [Abstract][Full Text] [Related]
4. 3,3'-Diindolylmethane attenuates cardiac H9c2 cell hypertrophy through 5'-adenosine monophosphate-activated protein kinase-α. Zong J; Wu QQ; Zhou H; Zhang JY; Yuan Y; Bian ZY; Deng W; Dai J; Li FF; Xu M; Fang Y; Tang QZ Mol Med Rep; 2015 Jul; 12(1):1247-52. PubMed ID: 25816057 [TBL] [Abstract][Full Text] [Related]
5. Insulin and metabolic stress stimulate multisite serine/threonine phosphorylation of insulin receptor substrate 1 and inhibit tyrosine phosphorylation. Hançer NJ; Qiu W; Cherella C; Li Y; Copps KD; White MF J Biol Chem; 2014 May; 289(18):12467-84. PubMed ID: 24652289 [TBL] [Abstract][Full Text] [Related]
6. The lipid peroxidation product 4-hydroxy-trans-2-nonenal causes protein synthesis in cardiac myocytes via activated mTORC1-p70S6K-RPS6 signaling. Calamaras TD; Lee C; Lan F; Ido Y; Siwik DA; Colucci WS Free Radic Biol Med; 2015 May; 82():137-46. PubMed ID: 25617592 [TBL] [Abstract][Full Text] [Related]
7. Phosphorylation of IRS1 at serine 307 in response to insulin in human adipocytes is not likely to be catalyzed by p70 ribosomal S6 kinase. Rajan MR; Fagerholm S; Jönsson C; Kjølhede P; Turkina MV; Strålfors P PLoS One; 2013; 8(4):e59725. PubMed ID: 23565163 [TBL] [Abstract][Full Text] [Related]
8. Serine 302 Phosphorylation of Mouse Insulin Receptor Substrate 1 (IRS1) Is Dispensable for Normal Insulin Signaling and Feedback Regulation by Hepatic S6 Kinase. Copps KD; Hançer NJ; Qiu W; White MF J Biol Chem; 2016 Apr; 291(16):8602-17. PubMed ID: 26846849 [TBL] [Abstract][Full Text] [Related]
9. AMP-activated protein kinase inhibits IGF-I signaling and protein synthesis in vascular smooth muscle cells via stimulation of insulin receptor substrate 1 S794 and tuberous sclerosis 2 S1345 phosphorylation. Ning J; Clemmons DR Mol Endocrinol; 2010 Jun; 24(6):1218-29. PubMed ID: 20363874 [TBL] [Abstract][Full Text] [Related]
10. Glucagon-like peptide-1 attenuates cardiac hypertrophy via the AngII/AT1R/ACE2 and AMPK/mTOR/p70S6K pathways. Wang J; Fan S; Xiong Q; Niu Y; Zhang X; Qin J; Shi Y; Zhang L Acta Biochim Biophys Sin (Shanghai); 2021 Aug; 53(9):1189-1197. PubMed ID: 34357376 [TBL] [Abstract][Full Text] [Related]
11. Carnosic Acid Attenuates the Free Fatty Acid-Induced Insulin Resistance in Muscle Cells and Adipocytes. Den Hartogh DJ; Vlavcheski F; Giacca A; MacPherson REK; Tsiani E Cells; 2022 Jan; 11(1):. PubMed ID: 35011728 [TBL] [Abstract][Full Text] [Related]
12. A possible linkage between AMP-activated protein kinase (AMPK) and mammalian target of rapamycin (mTOR) signalling pathway. Kimura N; Tokunaga C; Dalal S; Richardson C; Yoshino K; Hara K; Kemp BE; Witters LA; Mimura O; Yonezawa K Genes Cells; 2003 Jan; 8(1):65-79. PubMed ID: 12558800 [TBL] [Abstract][Full Text] [Related]
13. Exendin-4 attenuates cardiac hypertrophy via AMPK/mTOR signaling pathway activation. Zhou Y; He X; Chen Y; Huang Y; Wu L; He J Biochem Biophys Res Commun; 2015 Dec 4-11; 468(1-2):394-9. PubMed ID: 26519882 [TBL] [Abstract][Full Text] [Related]
14. [Effect of AMPK/mTOR/S6K1 pathways and the insulin-sensitizing effect for adiponectin in endometrial cancer cells]. Cai ZF; Deng L; Wang MM; Zhang JQ; Li L Zhonghua Fu Chan Ke Za Zhi; 2018 Aug; 53(8):554-560. PubMed ID: 30138966 [No Abstract] [Full Text] [Related]
15. AMPD1 regulates mTORC1-p70 S6 kinase axis in the control of insulin sensitivity in skeletal muscle. Tandelilin AA; Hirase T; Hudoyo AW; Cheng J; Toyama K; Morisaki H; Morisaki T BMC Endocr Disord; 2015 Mar; 15():11. PubMed ID: 25887856 [TBL] [Abstract][Full Text] [Related]
16. GPR39 promotes cardiac hypertrophy by regulating the AMPK-mTOR pathway and protein synthesis. Liao H; Gao W; Ma J; Xue H; Wang Y; Huang D; Yan F; Ye Y Cell Biol Int; 2021 Jun; 45(6):1211-1219. PubMed ID: 33554444 [TBL] [Abstract][Full Text] [Related]
17. Role of resistin in cardiac contractility and hypertrophy. Kim M; Oh JK; Sakata S; Liang I; Park W; Hajjar RJ; Lebeche D J Mol Cell Cardiol; 2008 Aug; 45(2):270-80. PubMed ID: 18597775 [TBL] [Abstract][Full Text] [Related]
18. Phosphorylation of the insulin receptor by AMP-activated protein kinase (AMPK) promotes ligand-independent activation of the insulin signalling pathway in rodent muscle. Chopra I; Li HF; Wang H; Webster KA Diabetologia; 2012 Mar; 55(3):783-94. PubMed ID: 22207502 [TBL] [Abstract][Full Text] [Related]
19. HTR2A promotes the development of cardiac hypertrophy by activating PI3K-PDK1-AKT-mTOR signaling. Gao W; Guo N; Zhao S; Chen Z; Zhang W; Yan F; Liao H; Chi K Cell Stress Chaperones; 2020 Nov; 25(6):899-908. PubMed ID: 32519137 [TBL] [Abstract][Full Text] [Related]
20. The mixed-lineage kinase 1-3 signalling pathway regulates stress response in cardiac myocytes via GATA-4 and AP-1 transcription factors. Ola A; Kerkelä R; Tokola H; Pikkarainen S; Skoumal R; Vuolteenaho O; Ruskoaho H Br J Pharmacol; 2010 Feb; 159(3):717-25. PubMed ID: 20067472 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]